18 and older, any sex, with Gout. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Outpatient Primary Care or Specialist Visits for Gout TreatmentPrimary· 3 months
Proportion of participants who attend a primary care or specialist visits for gout treatment
Group
Value
95% CI
Intervention
64
Control
35
Sponsor's own description
The prevalence of gout has been steadily increasing over several decades and is correlated with the rising burden of obesity, chronic cardiac and renal disease; all conditions overrepresented in the Southeastern U.S. - particularly in African Americans. Through a novel emergency department led intervention we aim to improve the care patients with gout receive, both during acute exacerbations and long-term. A secondary goal of the project is to concurrently enhance participation of minorities in biomedical research in the Deep South.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
NCT06508736 — Cyberbullying, Empathy, and Storytelling in Adolescents
· NA
· completed
NCT06297876 — COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color
· NA
· completed
NCT05399056 — Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling
· NA
· recruiting
NCT05865509 — Comparison of the Escape Room and Storytelling Methods in Learning the Stress Response
· NA
· completed
NCT04071470 — Storytelling to Increase Family Support for Pre Exposure Prophylaxis Use
· NA
· completed
Other recruiting trials for Gout
Currently open trials in the same condition.
NCT07414394 — Tigulixostat (IBI128) vs Febuxostat in Gout
· Phase 3
· recruiting
NCT07367971 — Drug-Drug Interaction Study of ABP-671 in Gout Patients
· Phase 1
· recruiting
NCT07346079 — Purified Cortrophin® Gel Efficacy and Safety Study of 2 Dose Levels in Patients With Acute Gout Flares
· Phase 4
· recruiting
NCT07089875 — A Study of Dotinurad Versus Allopurinol in Participants With Gout
· Phase 3
· recruiting
NCT05507723 — Tight Control of Gouty Arthritis Compared to Usual Care
· NA
· recruiting
Other University of Alabama at Birmingham trials
Trials by the same sponsor.
NCT04922229 — Comparative Effectiveness in the Management of Irreversible Pulpitis
· NA
· not yet recruiting
NCT05060380 — Feasibility of a Novel Resistance Exercise in Individuals With Osteoporosis
· NA
· withdrawn
NCT04768777 — Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis
· NA
· not yet recruiting
NCT06320951 — VITAL-IMPACT: Improving Cardiometabolic Health in Black Individuals Through Therapeutic Augmentation of Cyclic Guanosine
· Phase 2
· not yet recruiting
NCT07564934 — Leveraging Extended Reality Exergaming and Telehealth to Improve Physical Activity and Health in Children With Disabilit
· Phase 2
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Alabama at Birmingham
Last refreshed: 3 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04075903.